Monoclonal antibody administration. Current clinical pharmacokinetic status and future trends.
Begent
R H
RH
Department of Clinical Oncology, Royal Free Hospital School of Medicine, London, England.
Pedley
R B
RB
Begent
J
J
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000378:metabolism*; D000912:Antibodies, Neoplasm / Q000008:administration & dosage / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D004337:Drug Carriers; D006801:Humans; D000922:Immunotoxins / Q000008:administration & dosage / Q000378:metabolism; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D014018:Tissue Distribution
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D004337:Drug Carriers; D000922:Immunotoxins